مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
Normal view MARC view ISBD view

Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion. [electronic resource]

By:
  • Kang, Joon Hee
Contributor(s):
  • Lee, Seon-Hyeong
  • Lee, Jae-Seon
  • Nam, Boas
  • Seong, Tae Wha
  • Son, Jaekyoung
  • Jang, Hyonchol
  • Hong, Kyeong Man
  • Lee, Cheolju
  • Kim, Soo-Youl
Producer: 20180223Description: 49397-49410 p. digitalISSN:
  • 1949-2553
Subject(s):
  • Action Potentials
  • Adenosine Triphosphate -- metabolism
  • Aldehyde Dehydrogenase -- antagonists & inhibitors
  • Animals
  • Aspartic Acid -- metabolism
  • Carcinoma, Non-Small-Cell Lung -- drug therapy
  • Cell Line, Tumor
  • Cytosol -- metabolism
  • Female
  • Gossypol -- administration & dosage
  • Humans
  • Lung Neoplasms -- drug therapy
  • Malates -- metabolism
  • Membrane Potential, Mitochondrial
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Mitochondria -- metabolism
  • NAD -- metabolism
  • NADP -- metabolism
  • Neoplasm Transplantation
  • Oxidative Phosphorylation
  • Oxidoreductases Acting on CH-NH Group Donors
  • Phenformin -- administration & dosage
  • RNA, Small Interfering -- metabolism
Online resources:
  • Available from publisher's website
In: Oncotarget vol. 7
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.

APA

Kang J. H., Lee S., Lee J., Nam B., Seong T. W., Son J., Jang H., Hong K. M., Lee C. & Kim S. (20180223). Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion. : Oncotarget.

Chicago

Kang Joon Hee, Lee Seon-Hyeong, Lee Jae-Seon, Nam Boas, Seong Tae Wha, Son Jaekyoung, Jang Hyonchol, Hong Kyeong Man, Lee Cheolju and Kim Soo-Youl. 20180223. Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion. : Oncotarget.

Harvard

Kang J. H., Lee S., Lee J., Nam B., Seong T. W., Son J., Jang H., Hong K. M., Lee C. and Kim S. (20180223). Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion. : Oncotarget.

MLA

Kang Joon Hee, Lee Seon-Hyeong, Lee Jae-Seon, Nam Boas, Seong Tae Wha, Son Jaekyoung, Jang Hyonchol, Hong Kyeong Man, Lee Cheolju and Kim Soo-Youl. Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion. : Oncotarget. 20180223.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site